Mirae Asset Global Investments’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.2K | Buy |
4,162
+594
| +17% | +$1.46K | ﹤0.01% | 1488 |
|
2025
Q1 | $27.1K | Buy |
3,568
+530
| +17% | +$4.02K | ﹤0.01% | 1348 |
|
2024
Q4 | $35.7K | Sell |
3,038
-254
| -8% | -$2.99K | ﹤0.01% | 1321 |
|
2024
Q3 | $60.8K | Buy |
3,292
+582
| +21% | +$10.7K | ﹤0.01% | 1268 |
|
2024
Q2 | $58.1K | Sell |
2,710
-299,122
| -99% | -$6.41M | ﹤0.01% | 1217 |
|
2024
Q1 | $4.91M | Buy |
301,832
+129,358
| +75% | +$2.1M | 0.01% | 901 |
|
2023
Q4 | $5.17M | Sell |
172,474
-215,230
| -56% | -$6.45M | 0.01% | 884 |
|
2023
Q3 | $7.94M | Buy |
387,704
+31,653
| +9% | +$649K | 0.02% | 706 |
|
2023
Q2 | $7.08M | Buy |
356,051
+51,534
| +17% | +$1.02M | 0.02% | 795 |
|
2023
Q1 | $5.22M | Buy |
304,517
+20,084
| +7% | +$344K | 0.01% | 849 |
|
2022
Q4 | $5.57M | Sell |
284,433
-56,963
| -17% | -$1.11M | 0.01% | 788 |
|
2022
Q3 | $5.45M | Buy |
341,396
+78,396
| +30% | +$1.25M | 0.01% | 771 |
|
2022
Q2 | $3.62M | Buy |
263,000
+21,808
| +9% | +$300K | 0.01% | 939 |
|
2022
Q1 | $3.83M | Sell |
241,192
-31,212
| -11% | -$495K | 0.01% | 956 |
|
2021
Q4 | $5.95M | Buy |
272,404
+62,896
| +30% | +$1.37M | 0.01% | 840 |
|
2021
Q3 | $6.26M | Buy |
209,508
+43,930
| +27% | +$1.31M | 0.02% | 778 |
|
2021
Q2 | $7.33M | Buy |
165,578
+29,500
| +22% | +$1.31M | 0.02% | 722 |
|
2021
Q1 | $6.04M | Buy |
136,078
+73,124
| +116% | +$3.24M | 0.02% | 695 |
|
2020
Q4 | $3.45M | Buy |
62,954
+13,904
| +28% | +$762K | 0.01% | 750 |
|
2020
Q3 | $1.12M | Buy |
49,050
+15,824
| +48% | +$362K | 0.01% | 932 |
|
2020
Q2 | $696K | Buy |
33,226
+13,591
| +69% | +$285K | ﹤0.01% | 1028 |
|
2020
Q1 | $274K | Buy |
19,635
+2,147
| +12% | +$30K | ﹤0.01% | 1219 |
|
2019
Q4 | $398K | Buy |
17,488
+3,294
| +23% | +$75K | ﹤0.01% | 1293 |
|
2019
Q3 | $165K | Buy |
+14,194
| New | +$165K | ﹤0.01% | 1389 |
|